Til SFR for klinisk biokemi Konsekvenser ved implementering af ny dansk guideline for diagnostisk og opfølgning af M- komponent
![Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study | Protocol (Translated to Danish) Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study | Protocol (Translated to Danish)](https://www.jove.com/files/ftp_upload/54139/54139fig1large.jpg)
Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study | Protocol (Translated to Danish)
![PPT - M-komponent sygdomme diagnosticering, udredning, follow up, behandling m.m. Tolkningsproblemer PowerPoint Presentation - ID:582215 PPT - M-komponent sygdomme diagnosticering, udredning, follow up, behandling m.m. Tolkningsproblemer PowerPoint Presentation - ID:582215](https://image.slideserve.com/582215/udgangsstatus-for-monitorering-myelomatose-l.jpg)